Targeting the Activator Protein 1 Transcription Factor for the Prevention of Estrogen Receptor–Negative Mammary Tumors
暂无分享,去创建一个
S. Hilsenbeck | L. Chodosh | P. Brown | N. Colburn | Yun Zhang | Q. Shen | E. Gunther | Xìao-chun Xu | M. Young | Jamal L Hill | I. Uray | Yuxin Li
[1] P. Brown,et al. The AP-1 transcription factor regulates breast cancer cell growth via cyclins and E2F factors , 2008, Oncogene.
[2] Qiang Shen,et al. The AP-1 transcription factor regulates postnatal mammary gland development. , 2006, Developmental biology.
[3] P. Brown,et al. Receptor-selective retinoids inhibit the growth of normal and malignant breast cells by inducing G1 cell cycle blockade , 2006, Breast Cancer Research and Treatment.
[4] S. Hilsenbeck,et al. Global gene expression analysis of estrogen receptor transcription factor cross talk in breast cancer: identification of estrogen-induced/activator protein-1-dependent genes. , 2005, Molecular endocrinology.
[5] Qiang Shen,et al. AP-1 blockade in breast cancer cells causes cell cycle arrest by suppressing G1 cyclin expression and reducing cyclin-dependent kinase activity , 2004, Oncogene.
[6] M. Campiglio,et al. Re: Effect of epidermal growth factor receptor inhibitor on development of estrogen receptor-negative mammary tumors. , 2004, Journal of the National Cancer Institute.
[7] S. Hilsenbeck,et al. Effect of epidermal growth factor receptor inhibitor on development of estrogen receptor-negative mammary tumors. , 2004, Journal of the National Cancer Institute.
[8] N. Colburn,et al. Expression of dominant negative c-jun inhibits ultraviolet B-induced squamous cell carcinoma number and size in an SKH-1 hairless mouse model. , 2003, Molecular cancer research : MCR.
[9] J Cuzick,et al. Overview of the main outcomes in breast-cancer prevention trials , 2003, The Lancet.
[10] S. Hilsenbeck,et al. The retinoid X receptor-selective retinoid, LGD1069, prevents the development of estrogen receptor-negative mammary tumors in transgenic mice. , 2002, Cancer research.
[11] S. Hilsenbeck,et al. Inhibition of AP-1 transcription factor causes blockade of multiple signal transduction pathways and inhibits breast cancer growth , 2002, Oncogene.
[12] Chris Albanese,et al. Opposing Action of Estrogen Receptors α and β on Cyclin D1 Gene Expression* , 2002, The Journal of Biological Chemistry.
[13] Robert B Boxer,et al. A novel doxycycline‐inducible system for the transgenic analysis of mammary gland biology , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[14] Shokei Kim,et al. Effects of Dominant‐Negative c‐Jun on Platelet‐Derived Growth Factor‐Induced Vascular Smooth Muscle Cell Proliferation , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[15] Y. Geng,et al. Specific protection against breast cancers by cyclin D1 ablation , 2001, Nature.
[16] S. Hilsenbeck,et al. AP-1 blockade inhibits the growth of normal and malignant breast cells , 2001, Oncogene.
[17] M. Karin,et al. AP-1 Repressor Protein JDP-2: Inhibition of UV-Mediated Apoptosis through p53 Down-Regulation , 2001, Molecular and Cellular Biology.
[18] S. Hilsenbeck,et al. Oxidative stress and AP-1 activity in tamoxifen-resistant breast tumors in vivo. , 2000, Journal of the National Cancer Institute.
[19] F. Lin,et al. Unique anti-activator protein-1 activity of retinoic acid receptor beta. , 2000, Cancer research.
[20] I. Ellis,et al. Biological and clinical associations of c‐jun activation in human breast cancer , 2000, International journal of cancer.
[21] P. Brown,et al. cJun overexpression in MCF-7 breast cancer cells produces a tumorigenic, invasive and hormone resistant phenotype , 1999, Oncogene.
[22] K. Milde-Langosch,et al. Expression pattern of the AP‐1 family in breast cancer: Association of fosB expression with a well‐differentiated, receptor‐positive tumor phenotype , 1999, International journal of cancer.
[23] B. Katzenellenbogen,et al. The estrogen receptor enhances AP-1 activity by two distinct mechanisms with different requirements for receptor transactivation functions. , 1999, Molecular endocrinology.
[24] N. Colburn,et al. Transgenic mice demonstrate AP-1 (activator protein-1) transactivation is required for tumor promotion. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[25] N. Colburn,et al. Expression of dominant negative Jun inhibits elevated AP-1 and NF-κB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes , 1998, Oncogene.
[26] S. Elledge,et al. Isolation of an AP-1 repressor by a novel method for detecting protein-protein interactions , 1997, Molecular and cellular biology.
[27] E. Zandi,et al. AP-1 function and regulation. , 1997, Current opinion in cell biology.
[28] P. Brown,et al. Activation and inhibition of the AP‐1 complex in human breast cancer cells , 1996, Molecular carcinogenesis.
[29] L. Rubin,et al. A c-jun dominant negative mutant protects sympathetic neurons against programmed cell death , 1995, Neuron.
[30] L. Giudice,et al. Patterns of matrix metalloproteinase expression in cycling endometrium imply differential functions and regulation by steroid hormones. , 1994, The Journal of clinical investigation.
[31] M. Birrer,et al. Mechanism of action of a dominant-negative mutant of c-Jun. , 1994, Oncogene.
[32] Z. Dong,et al. Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[33] M. Birrer,et al. Suppression of oncogene-induced transformation by a deletion mutant of c-jun. , 1993, Oncogene.
[34] M. Karin,et al. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. , 1991, Biochimica et biophysica acta.
[35] M. Birrer,et al. The role of jun and fos gene family members in 12-O-tetradecanoylphorbol-13-acetate induced hemopoietic differentiation. , 1991, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[36] S. Kliewer,et al. Retinoic acid is a negative regulator of AP-1-responsive genes. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[37] A. Nienhuis,et al. Inducible production of c-fos antisense RNA inhibits 3T3 cell proliferation. , 1986, Proceedings of the National Academy of Sciences of the United States of America.